Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Autoimmune Diseases”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Early research (Phase 1)Looking for participantsNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Testing effectiveness (Phase 2)Looking for participantsNCT06428188
What this trial is testing

Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Lupus Erythematosus Acute+1 more
Essen Biotech 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07190261
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Bing Han 3
Early research (Phase 1)Looking for participantsNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Very early researchWithdrawnNCT06866080
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Testing effectiveness (Phase 2)Ended earlyNCT05168475
What this trial is testing

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Who this might be right for
Giant Cell ArteritisTakayasu ArteritisCogan Syndrome+6 more
Cambridge University Hospitals NHS Foundation Trust 22
Early research (Phase 1)Looking for participantsNCT06316076
What this trial is testing

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more
RenJi Hospital 48
Large-scale testing (Phase 3)Active Not RecruitingNCT05263934
What this trial is testing

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis
GlaxoSmithKline 163
Not applicableNot Yet RecruitingNCT06847607
What this trial is testing

Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

Who this might be right for
AIHA - Warm Autoimmune Hemolytic AnemiaAIHA - Cold Autoimmune Hemolytic Anemia
Bing Han 20
Early research (Phase 1)Looking for participantsNCT07315087
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableLooking for participantsNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Very early researchNot Yet RecruitingNCT07275736
What this trial is testing

CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
Juventas Cell Therapy Ltd. 18
Very early researchLooking for participantsNCT06680388
What this trial is testing

CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Institute of Hematology & Blood Diseases Hospital, China 15
Very early researchStudy completedNCT05080270
What this trial is testing

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
FibroBiologics 5
Testing effectiveness (Phase 2)Study completedNCT00716651
What this trial is testing

Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

Who this might be right for
Churg Strauss Syndrome
University Hospital Schleswig-Holstein 10
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Very early researchNot Yet RecruitingNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Load More Results